PROBLEM: HLA-G expression is related as an immune modulator of fetal-maternal tolerance, and its levels was correlated with pregnancy outcome. In a case-control study, we investigate the association between the genetic variability of the HLA-G gene and serum levels of soluble HLA-G in cases of embryo implantation failure. METHOD OF STUDY: Forty couples with at least two unsuccessful fresh embryo transfers (implantation failure; IF) and 83 fertile couples with at least two successful pregnancies was genotyped by sequencing-based typing. HLA-G alleles were defined by nucleotide sequence variations at exon 2, 3, and 4, and the quantification of soluble HLA-G (sHLA-G) was performed by ELISA. RESULTS: There was a significant difference between the HLA-G allelic distributions between IF couples and the control couples. The HLA-G*01:03:01 allele was increased in the IF couples. There were no significant differences in the serum levels of sHLA-G in the IF and control groups. CONCLUSION: The results suggest that the distribution of HLA-G products may play a significant role in the modulation of maternal-fetal immune response.
PROBLEM: HLA-G expression is related as an immune modulator of fetal-maternal tolerance, and its levels was correlated with pregnancy outcome. In a case-control study, we investigate the association between the genetic variability of the HLA-G gene and serum levels of soluble HLA-G in cases of embryo implantation failure. METHOD OF STUDY: Forty couples with at least two unsuccessful fresh embryo transfers (implantation failure; IF) and 83 fertile couples with at least two successful pregnancies was genotyped by sequencing-based typing. HLA-G alleles were defined by nucleotide sequence variations at exon 2, 3, and 4, and the quantification of soluble HLA-G (sHLA-G) was performed by ELISA. RESULTS: There was a significant difference between the HLA-G allelic distributions between IF couples and the control couples. The HLA-G*01:03:01 allele was increased in the IF couples. There were no significant differences in the serum levels of sHLA-G in the IF and control groups. CONCLUSION: The results suggest that the distribution of HLA-G products may play a significant role in the modulation of maternal-fetal immune response.
Authors: Vanessa Hauer; Matilde Risti; Bruna L M Miranda; José S da Silva; Ana L Cidral; Carolina M Pozzi; Fabiana L de C Contieri; Ibrahim A Sadissou; Eduardo A Donadi; Danillo G Augusto; Maria da G Bicalho Journal: PLoS One Date: 2019-02-22 Impact factor: 3.240
Authors: Erick C Castelli; Bibiana S de Almeida; Yara C N Muniz; Nayane S B Silva; Marília R S Passos; Andreia S Souza; Abigail E Page; Mark Dyble; Daniel Smith; Gabriela Aguileta; Jaume Bertranpetit; Andrea B Migliano; Yeda A O Duarte; Marília O Scliar; Jaqueline Wang; Maria Rita Passos-Bueno; Michel S Naslavsky; Mayana Zatz; Celso Teixeira Mendes-Junior; Eduardo A Donadi Journal: Sci Rep Date: 2021-11-29 Impact factor: 4.379
Authors: Burcu Duygu; Timo I Olieslagers; Mathijs Groeneweg; Christina E M Voorter; Lotte Wieten Journal: Front Immunol Date: 2021-07-06 Impact factor: 7.561
Authors: Radia Boudjenah; Denise Molina-Gomes; Antoine Torre; Florence Boitrelle; Stéphane Taieb; Esther Dos Santos; Robert Wainer; Philippe de Mazancourt; Jacqueline Selva; François Vialard Journal: PLoS One Date: 2014-09-23 Impact factor: 3.240